BNP Paribas Aktienanleihe BAYN 27.../ DE000PE0B634 /
2024-06-03 10:01:41 AM | Chg.+0.38 | Bid7:02:21 PM | Ask7:02:21 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
56.89EUR | +0.67% | 57.60 Bid Size: 60,000 |
57.70 Ask Size: 60,000 |
BAYER AG NA O.N. | 50.00 - | 2024-06-27 | Call |
GlobeNewswire
4:00 PM
Revolutionary Baytec®SPR Membrane from Taiwan Hydroseal Demonstrates 20 Years of Excellence and Inno...
GlobeNewswire
8:30 AM
Orion is developing the Finnish life science industry in a unique collaboration project
GlobeNewswire
8:00 AM
FTI Consulting Adds Senior Chemicals Industry Expert to Further Expand Business Transformation Pract...
GlobeNewswire
05-30
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
GlobeNewswire
05-30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
05-28
Pairwise and Bayer Expand CRISPR Leafy Greens Market through Licensing Agreement
GlobeNewswire
05-02
AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting...
GlobeNewswire
04-18
AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in conge...
GlobeNewswire
04-16
AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire
04-11
Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire
03-25
BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rar...
GlobeNewswire
03-06
BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive tren...
GlobeNewswire
03-04
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
GlobeNewswire
02-15
2Blades Delivers on Project with Bayer Crop Science to Combat Asian Soybean Rust
GlobeNewswire
02-13
Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...